Business Insider reviewed data from venture capital, private equity and mergers and acquisitions database company PitchBook to compile a list of the 25 most valuable venture capital-backed startups that shuttered in 2018. The healthcare industry was well represented on the list, accounting for seven of the 25 startups.
Here are the seven most valuable healthcare technology startups that failed in 2018:
1. Theranos: Blood-testing technology ($9 billion valuation)
8. Medical Simulation: Simulation products for medical training ($194 million valuation)
9. ReVision Optics: Surgical implants for vision loss ($183 million valuation)
12. Candescent Health: Radiology software ($145 million valuation)
13. Paieon: Medical imaging technology ($136 million valuation)
15. Winx: Sleep-therapy systems ($115 million valuation)
22. Claritas Genomics: Pediatric genetic testing ($60 million valuation)
To read the list of the 25 most valuable startups that failed in all industries, click here.
More articles on health IT:
How to join Apple’s health records project
Microsoft releases development kit for blockchain applications
Northwestern introduces AI tool to help medical assistants conduct sonograms
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
